Copyright
©The Author(s) 2021.
World J Clin Cases. Oct 16, 2021; 9(29): 8627-8646
Published online Oct 16, 2021. doi: 10.12998/wjcc.v9.i29.8627
Published online Oct 16, 2021. doi: 10.12998/wjcc.v9.i29.8627
Type 1 | Type 2 | Type 3 | |
Distribution, % | 70-80 | 5-6 | 15-30 |
Gender predominance | F > M | F = M | M > F |
Associated disease | Atrophic gastritis, pernicious anemia | ZES/MEN1 | None |
Location: gastric | Body, fundus | Body, fundus | Anywhere |
Tumor | |||
Number | > 1 | >1 | 1 |
Size: Generally | < 1 cm | < 1 cm, > 1 cm | > 2 cm |
Mucosa | Atrophic | Hypertrophic | Normal |
Gastrin level | Hypergastrinemia | Hypergastrinemia | Normal |
Gastric pH | High | Low | Normal |
Treatment | Endoscopic, Surgery | Endoscopic, Surgery | Surgery, LND |
Prognosis, survival % | 100 | 60-90 | 50 |
- Citation: Yozgat A, Kekilli M, Altay M. Time to give up traditional methods for the management of gastrointestinal neuroendocrine tumours. World J Clin Cases 2021; 9(29): 8627-8646
- URL: https://www.wjgnet.com/2307-8960/full/v9/i29/8627.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i29.8627